Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

ClinicalTrials.gov ID: NCT00312286

Public ClinicalTrials.gov record NCT00312286. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 22, 2026, 6:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled Phase II Study of Multiple Dosing Regimens of Intravaginally Administered 851B Gel for the Treatment of Cervical High Risk HPV Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to evaluate efficacy of 851B gel over a range of concentrations and dosing regimens on high-risk cervical human papillomavirus infection in women.

Study identification

NCT ID: NCT00312286
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 2
Lead sponsor: Takeda; Industry
Enrollment: 538 participants

Conditions and interventions

Conditions

Papillomavirus Infections

Interventions

851B Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 45 Years
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 2006 (Type not available)
Primary completion: Jun 2008 (Actual)
Completion: Jun 2008 (Actual)
Last update posted: Sep 23, 2016

2006 – 2008

United States locations

U.S. sites: 88
U.S. states: 34
U.S. cities: 88

Facility	City	State	ZIP	Site status
Not listed	Birmingham	Alabama	—	—
Not listed	Enterprise	Alabama	—	—
Not listed	Huntsville	Alabama	—	—
Not listed	Montgomery	Alabama	—	—
Not listed	Chandler	Arizona	—	—
Not listed	Phoenix	Arizona	—	—
Not listed	Tucson	Arizona	—	—
Not listed	Jonesboro	Arkansas	—	—
Not listed	Carmichael	California	—	—
Not listed	Colton	California	—	—
Not listed	San Diego	California	—	—
Not listed	San Francisco	California	—	—
Not listed	Santa Rosa	California	—	—
Not listed	Colorado Springs	Colorado	—	—
Not listed	Longmont	Colorado	—	—
Not listed	Louisville	Colorado	—	—
Not listed	Danbury	Connecticut	—	—
Not listed	Groton	Connecticut	—	—
Not listed	Aventura	Florida	—	—
Not listed	Boynton Beach	Florida	—	—
Not listed	Clearwater	Florida	—	—
Not listed	Fort Myers	Florida	—	—
Not listed	Leesburg	Florida	—	—
Not listed	Miami	Florida	—	—
Not listed	Pembroke Pines	Florida	—	—
Not listed	Plantation	Florida	—	—
Not listed	Tampa	Florida	—	—
Not listed	West Palm Beach	Florida	—	—
Not listed	Atlanta	Georgia	—	—
Not listed	Augusta	Georgia	—	—
Not listed	Decatur	Georgia	—	—
Not listed	Savannah	Georgia	—	—
Not listed	Woodstock	Georgia	—	—
Not listed	Boise	Idaho	—	—
Not listed	Idaho Falls	Idaho	—	—
Not listed	Evansville	Indiana	—	—
Not listed	Des Moines	Iowa	—	—
Not listed	Iowa City	Iowa	—	—
Not listed	Louisville	Kentucky	—	—
Not listed	Marrero	Louisiana	—	—
Not listed	Metairie	Louisiana	—	—
Not listed	Detroit	Michigan	—	—
Not listed	Paw Paw	Michigan	—	—
Not listed	Chaska	Minnesota	—	—
Not listed	St Louis	Missouri	—	—
Not listed	Las Vegas	Nevada	—	—
Not listed	Reno	Nevada	—	—
Not listed	Lebanon	New Hampshire	—	—
Not listed	Newark	New Jersey	—	—
Not listed	Albuquerque	New Mexico	—	—
Not listed	New York	New York	—	—
Not listed	The Bronx	New York	—	—
Not listed	Chapel Hill	North Carolina	—	—
Not listed	Charlotte	North Carolina	—	—
Not listed	Durham	North Carolina	—	—
Not listed	New Bern	North Carolina	—	—
Not listed	Winston-Salem	North Carolina	—	—
Not listed	Bismarck	North Dakota	—	—
Not listed	Fargo	North Dakota	—	—
Not listed	Gallipolis	Ohio	—	—
Not listed	Oklahoma City	Oklahoma	—	—
Not listed	Eugene	Oregon	—	—
Not listed	Medford	Oregon	—	—
Not listed	Erie	Pennsylvania	—	—
Not listed	Philadelphia	Pennsylvania	—	—
Not listed	Pittsburgh	Pennsylvania	—	—
Not listed	Pottstown	Pennsylvania	—	—
Not listed	West Reading	Pennsylvania	—	—
Not listed	Wynnewood	Pennsylvania	—	—
Not listed	Columbia	South Carolina	—	—
Not listed	Greenville	South Carolina	—	—
Not listed	Watertown	South Dakota	—	—
Not listed	Bristol	Tennessee	—	—
Not listed	Chattanooga	Tennessee	—	—
Not listed	Clarksville	Tennessee	—	—
Not listed	Memphis	Tennessee	—	—
Not listed	Nashville	Tennessee	—	—
Not listed	Austin	Texas	—	—
Not listed	Carrollton	Texas	—	—
Not listed	Dallas	Texas	—	—
Not listed	Houston	Texas	—	—
Not listed	Plano	Texas	—	—
Not listed	San Antonio	Texas	—	—
Not listed	Sandy City	Utah	—	—
Not listed	Richmond	Virginia	—	—
Not listed	Virginia Beach	Virginia	—	—
Not listed	Renton	Washington	—	—
Not listed	Seattle	Washington	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00312286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 23, 2016 · Synced Oct 22, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00312286 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →